EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
Journal article published in 2016 by
Eskil Eskilsson,
Gv Rosland,
Km Talasila,
Stian Knappskog,
Olivier Keunen,
Andrea Sottoriva,
Sarah Foerster,
Gergely Solecki,
Torfinn Taxt,
Radovan Jirik,
Sabrina Fritah 
,
Pn Harter,
Kristjan Valk,
Jubayer Al Hossain,
Jv Joseph
and other authors.
,
Pn Harter,
Kristjan Valk,
Jubayer Al Hossain,
Jv Joseph
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Amplification of the epidermal growth factor receptor (EGFR) and its mutant EGFRvIII are among the most common genetic alterations in glioblastoma (GBM), the most frequent and most aggressive primary brain tumor.